Dexcom G7 for Abnormal Glucose Metabolism

Recruiting in Palo Alto (17 mi)

Overseen byMegan Hicks, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Wake Forest University Health Sciences

No Placebo Group

Trial Summary

What is the purpose of this trial?The purpose of this research study is to test the accuracy of the Dexcom continuous glucose monitoring device during the cardiothoracic surgical procedure and recovery period in the Cardiac Intensive Care Unit. Readings from the device will be compared with the standard of care blood glucose levels that are obtained during your surgery and postoperatively.

Eligibility Criteria

This trial is for patients with diabetes or liver metabolic disorders who are undergoing cardiopulmonary bypass surgery. Participants should have abnormal glucose metabolism and will be monitored during and after their heart surgery.

Inclusion Criteria

I am scheduled for heart surgery with a heart-lung machine at Atrium Health Wake Forest Baptist.

I am 18 years old or older.

Exclusion Criteria

I am younger than 18.

I don't have a rash, missing arm, or a device that would interfere with a new device placement on my arm.

Pregnant women

Participant Groups

The study is testing the Dexcom G7 Continuous Glucose Monitor's accuracy against standard blood glucose tests during and after cardiac surgery in the intensive care unit.

1Treatment groups

Experimental Treatment

Group I: Continuous Glucose MonitoringExperimental Treatment1 Intervention

All participants will wear the Dexcom G7 continuous glucose monitor continuously during their cardiothoracic surgery and throughout their time admitted to the Cardiovascular Intensive Care Unit.